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Abstract
Influenza infection requires viral escape from early endosomes into the cytosol, which is enabled by an acid-induced irreversible
conformational transformation in the viral protein hemagglutinin. Despite the direct relationship between this conformational
change and infectivity, label-free methods for characterizing this and other protein conformational changes in biological mixtures
are limited. While the chemical reactivity of the protein backbone and side-chain residues is a proxy for protein conformation,
coupling this reactivity to quantitative mass spectrometry is a challenge in complex environments. Herein, we evaluate whether
electrophilic amidination coupled with pseudo-parallel reaction monitoring is an effective label-free approach to detect the
fusion-associated conformational transformation in recombinant hemagglutinin (rHA). We identified rHA peptides that are
differentially amidinated between the pre- and post-fusion states, and validated that this difference relies upon the fusion-
associated conformational switch. We further demonstrate that we can distinguish the fusion profile in a matrix of digested
cellular lysate. This fusion assay can be used to evaluate fusion competence for modified HA.
Keywords Protein conformation . Protein amidination . Mass spectrometry . Parallel reaction monitoring . Viral fusion .
Hemagglutinin
Introduction
Influenza virus is a major cause of respiratory disease, causing
> 300,000 deaths in a typical year, millions to tens of millions
of deaths in pandemic years, and extensive loss of economic
activity [1]. An obligate step in viral infection is fusion of the
viral membrane with the endosomal membrane, which allows
for release of the viral RNA-polymerase complex (RNPs) into
the host cytosol. This fusion is driven by an acid-induced
conformational change in the viral coat protein hemagglutinin
(HA). Because fusion is essential for infection, fusion inhibi-
tion has been an intensively pursued approach to block influ-
enza infection using small molecules. Although recent studies
have elucidated the biochemical mechanism of HA-mediated
fusion [2, 3], the sequence dependence and particularly intra-
cellular factors that govern HA fusion competence are still
unclear. Largely, this is due to a lack of tools to readily char-
acterize HA conformational changes inside the cell.
Mature HA (cleaved to two domains: HA1 and HA2)
mediates viral endocytosis into the cell through engagement
of the sialic acid receptor by the HA1 domain. Under the
acidic conditions of the early endosome, HA undergoes a
global conformational change [4], including extensive re-
modeling of both HA1 and HA2 domains. As a result, an
N-terminal region of HA2, termed the fusion peptide, is
exposed. The fusion peptide embeds into the endosomal
membrane, promoting fusion with the viral membrane and
subsequent release of the viral genome into the cytosol. The
most dramatic structural change takes place over the HA2
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region in the stalk domain near the C-terminus; acidification
and conversion to the post-fusion state lead to a substantial
increase in solvent exposure in this region. Given the large
change in solvent engagement over the entirety of HA, we
hypothesized that profiling reactions would be sensitive to
the fusion event.
Hence, we set out to develop a label-free, targeted ap-
proach to interrogate HA fusion competence. The gold stan-
dard for profiling protein conformation is hydrogen-
deuterium exchange (HDX) [5], which has been successfully
applied to fully characterize solvent exposure throughout
HA in both pre- and post-fusion states [2]. HDX has several
limitations, however, including incompatibility with biolog-
ically complex matrices, the requirement for rapid, high-
resolution separation, and usually high nanogram to micro-
gram levels of sample. To overcome these challenges, oxi-
dative and electrophilic labeling approaches have been taken
to footprint water accessibility on protein surfaces, both in
buffer and in complex media [6–10]. Among oxidative ap-
proaches, SPROX employs peroxide to oxidize methionine
residues [9, 11], while FPOP generates oxidizing radicals
through photolysis [12–15]. Electrophilic approaches include
targeting lysine with NHS esters [16, 17], oxyimidates, and
thioimidates [18–20], and targeting glutamate and aspartate
with glycine ethyl ester [21–23]. Thioimidate reagents are
notable in that they are cell-penetrable, selectively label an
abundant amino acid (lysine), provide a homogenous reac-
tion product allowing straightforward spectral assignment,
promote ionization during electrospray, and do not modify
residue charge, which can itself alter protein conformation
[24].
Previously, thioimidates have been applied to discover
changes in intracellular protein conformation using data-
dependent analysis, yielding similar performance to
SPROX. However, when targeting specific modifications,
greater sensitivity and robustness can be achieved by using
targeted, data-independent methods. Although being re-
quired to assay for a specific peptide, as opposed to the best
performing peptides in an entire protein, sharply constrains
target peptide choice, multiple reaction monitoring (MRM)
and parallel reaction monitoring (PRM) have proven effec-
tive for quantifying PTMs [25, 26] and adduct sites [27].
Hence, we considered that electrophilic profiling by S-
methylthioacetimidate (SMTA), followed by reaction moni-
toring, might be an effective strategy to identify pre- and
post-fusion HA conformational states. Herein, we implement
a targeted MS/MS technique of pseudo-parallel reaction
monitoring to quantify labeling of the pre- and post-fusion
HAs. We find that SMTA efficiently labels HA,
distinguishing the pre- and post-fusion states, and that we
can measure this difference using reaction monitoring. This
will enable the further development of assays to assess HA
viral fusion competence.
Materials and methods
Materials
Sodium phosphate, sodium chloride, HEPES, Tris, MS-grade
methanol, MS-grade acetonitrile, and chloroformwere obtain-
ed from Fisher (Pittsburgh, PA, USA). Tissue-culture grade
dimethyl sulfoxide was obtained from Corning (Corning, NY,
USA). Urea, formic acid, TCEP, and iodoacetamide were ob-
tained from Acros (a division of Fisher). Sodium citrate was
obtained from VWR (Radnor, PA, USA). Imidazole was ob-
tained from Sigma (Burlington, VA, USA). Phosphate-
buffered saline (PBS; 10 mM phosphate, 150 mM sodium,
pH 7.4) was obtained from GE Healthcare (Chicago, IL,
USA).
Preparation and purification of recombinant
hemagglutinins
HEK293T was obtained from ATCC (Manassas, VA, USA).
The cells were cultured in complete media containing DMEM
(Corning) supplemented with 10% FBS (Seradigm, a division
of VWR), 1%L-glutamine (Corning), and 1% penicillin strep-
tomycin (Corning). HAwas prepared as previously described
[28]. Briefly, PR8HA-6xHistag (strain A/Puerto Rico/8/1934
H1N1) expressing plasmid was transfected to HEK293T cells
by the PEI transfection method. After 72 h, the cultured media
were cleared by low speed centrifugation (3500 rpm, 20 min,
4 °C) and the HA was purified by His6 Ni Superflow resin
(Clontech) overnight at 4 °C. The resin media were passed
through 10 mL polypropylene columns (Qiagen,
Germantown, MD, USA). The retained resin was washed 4
times with wash buffer (50 mM NaH2PO4, 30 mM NaCl,
20 mM imidazole, pH 8.0). The protein was eluted with elu-
tion buffer (50 mM NaH2PO4, 30 mM NaCl, 250 mM imid-
azole, pH 8.0). The eluate was concentrated using an Amicon
10 kDa MWCO spin column (Merck Millipore, Burlington,
MA, USA) and dialyzed 4 times with PBS and quantified by
Thermo Nanodrop 3.0 (Thermo, Waltham, MA, USA). Purity
was evaluated by Silver Stain [29].
Acid-induced activation of recombinant HA
PR8 was chosen as the HA wild-type model for the study.
Purified recombinant PR8 HA was diluted in PBS buffer. To
pre-cleave the precursor HA0 to HA1 and HA2, TPCK-treated
trypsin was added to the protein at a ratio of 10:1 (protein-to-
protease) and incubated with 600 rpm shaking at 37 °C for
5 min. Pre-cleavage was quenched with 1 mM PMSF
(Sigma), which remains in the sample solution through later
steps. The pH of PR8 HA solution was brought to pH 4.9 by
adding citrate buffer at pH 3.0 to a final citrate concentration of
7.0 mM. The acidified HA was incubated at ambient
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temperature for 3 h, then brought to pH 8.0 by 20 mM phos-
phate pH 11.00. The neutral control sample was treated in the
same manner with citrate pH 7.4 to a final citrate concentration
of 7.0 mM. Both acidified and neutral samples were brought to
equal volumes by PBS. The fusion inhibitor [30] arbidol-HCl
(Fisher) was added as indicated in DMSO following pre-
cleavage at a concentration of 400 μM and incubated for
30 min at ambient temperature prior to acidification. Control
samples received 4% DMSO vehicle alone.
Trypsin susceptibility of acid-induced HA
The treated HA above was incubated at 37 °C for 3 h to
deactivate PMSF, then was digested with TPCK-trypsin
(Sigma) at 5:1 (protein:protease ratio) for 30 min at 37 °C,
shaken at 600 rpm [31]. Immediately after being digested, the
samples were denatured and reduced in 1X Laemmli buffer
(12% SDS (w/v), 0.06% bromophenol blue (w/v), 47% glyc-
erol (v/v), and 60 mM Tris pH 6.8) and 20 mM DTT. The
denatured protein was boiled at 100 °C for 5 min. The digest
was separated on 12% reducing SDS-PAGE gel for silver
staining.
SMTA labeling of recombinant HA
SMTA was prepared as the hydrogen iodide salt from
thioacetamide (Sigma) and methyl iodide (Sigma), as previ-
ously described [18], and aliquots stored under Ar at − 80 °C.
Aliquots were freshly dissolved prior to labeling in 25 mM
HEPES, 50 mM NaCl pH 7.4 at 200 mM SMTA, which was
then neutralized with sodium hydroxide. SMTA solution was
added to PR8HA samples, mixed well and let sit for 30 min at
ambient temperature. The reaction was quenched by
methanol-chloroform precipitation, by adding 4 equivalents
methanol, 1 equivalent chloroform, and 3 equivalents water
with vortexing after each addition, followed by sedimentation
of protein to the interphase at 10,000×g for 5 min. The aque-
ous layer was removed and the protein pellet washedwell with
methanol and air-dried.
Sample preparation for mass spectrometry
Air-dried protein pellets were solubilized in freshly prepared
9 M urea in 50 mM Tris pH 8.0. Ten millimolar aqueous
TCEP was added to reduce the disulfide bonds for 30 min in
the dark at room temperature. Five millimolar aqueous
iodoacetamide was added to alkylate the sulfhydryl groups
for 15min in the dark at room temperature. The solutions were
diluted with 50 mMTris pH 8.0 to 2 M urea and digested with
sequencing grade porcine trypsin (Thermo) or Glu-C
(Thermo) at a ratio of 20:1 protein-to-protease for 18 to 24 h
at 37 °C, shaken at 600 rpm. After digestion, the samples were
acidified with 5% formic acid and debris eliminated at
21,100×g for 30 min.
Preparation of complex mixtures containing digested
HA
HEK293Tcells were harvested by scrapping in PBS and lysed
in RIPA buffer (50 mMTris pH 7.5, 150 mMNaCl, 1% Triton
X-100, 0.5% deoxycholate, 0.1% SDS) or by freeze-thaw in
PBS. The lysate concentration was quantified by Bradford
assay (Bio-rad, Hercules, CA, USA) with the measurement
by Varian Cary 60 UV/Vis spectrophotometer (Agilent,
Santa Clara, CA, USA). The protein was precipitated by
methanol-chloroform precipitation and prepared as digested
peptides similar to the above description. Digested peptides
from either acidified or neutral as described above was spiked
in lysate at 10% (w/w). One microgram lysate was analyzed
by pseudo-PRM in the LTQ Orbitrap Velos Pro (Thermo).
Data-dependent analysis of SMTA-labeled PR8 HA
Digest was injected from the autosampler of an Easy-nLC
1000 to the trapping column containing a Kasil frit and 2-cm
5 μm C18 resin (Phenomenex). High salt concentration was
removed by washing with buffer A through the waste line.
The analytical column is a pulled 5 um tip packed with 15-
to 20-cm 3 μmC18 resin (Phenomenex, Torrance, CA, USA).
The peptides were injected directly onto the trapping column
at a flow rate of 5.0 μL/min and separated on the analytical
column at a flow rate of 500 nL/min. Buffer Awas 5% aceto-
nitrile, 0.1% formic acid, and buffer B was 80% acetonitrile,
0.1% formic acid. The gradient conditions were as follows: 0–
5 min: 1–7%B; 5–95min: 7–55%B; 95–115min: 55–100%B;
115–120 min: 100%B; 120–125 min: 100–1%B; 125–
145 min: 1%B. The eluate was sprayed at 3.0 kVand the ion
transfer tube maintained at 275 °C. The mass spectrometer
(LTQ Orbitrap Velos Pro) precursor scan was acquired with
the AGC set to 105 and 50 ms maximum injection time. In all
data acquisition strategies, MS2 scans were acquired by CID
at a normalized collision energy set to 35 kV.
Targeted library generation
Data-dependent acquisition of MS/MS spectra with the linear
ion trap in the LTQ Orbitrap Velos Pro were performed with
the following settings: MS/MS on the 10most intense ions per
precursor scan, dynamic exclusion repeat count, 1, repeat du-
ration, 30 s; exclusion list size, 500; and exclusion duration,
5 s. The raw data was extracted using Raw Converter to MS1
and MS2 spectral files. These files were searched against a
database of the PR8 HA sequence and its reversed sequence
by the ProLucid algorithm in the IP2 software suite
(Integrated Proteomics, San Diego, CA) [32]. The database
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was supplemented with forward and reverse (decoy) se-
quences for 400 common contaminants (e.g., keratins, immu-
noglobulins, albumen). The precursor mass tolerance was set
to 3000.0 m-amu, and the fragment mass tolerance was set to
600.0 ppm. The search space included up to 3 missed cleaved
tryptic peptides. Carbamidomethylation (+ 57.02146) of cys-
teine was considered as a static modification. Amidination of
lysine (+ 41.02655) was permitted as a differential modifica-
tion. Peptide candidates were filtered using DTASelect for less
than 1% false positive peptides [33].
Pseudo-PRM analysis
From data-dependent analysis, the precursors were chosen such
that their spectral counts are > 3 and they are fully tryptic
peptides (Table 1). From each precursor, the 3 most intense
fragments were chosen for monitoring. The peptides were
injected directly to the trapping column at a flow rate of
5.0 μL/min and separated on the analytical column at a flow
rate of 350 nL/min. Buffer Awas 5% acetonitrile, 0.1% formic
acid, and buffer B was 80% acetonitrile, 0.1% formic acid. The
gradient conditions were as follows: 0–1 min: 1–7%B; 1–
59 min: 7–35%B; 59–64 min: 35–100%B; 64–69 min:
100%B; 69–74 min: 100–1%B; 74–94 min: 1%B. The moni-
toring time for each peptide was 10 min. In the linear ion trap,
the precursor scan was acquired at normal resolution, with the
AGC set to 104 and 50 ms maximum injection time and isola-
tionwidth of 1.0m/z. In the FTOrbitrap, the precursor scanwas
acquired at a resolution of 15,000, with the AGC set to 5 × 104,
isolation width of 1.0 m/z, and 25 ms maximum injection time.
The three most intense product ions were chosen for quantifi-
cation. The integration of each transition was measured from
the extracted ion chromatogram from Xcalibur and summed to
obtain the total integration of each peptide. The m/z windows
used to extract the transitions for quantification in the linear ion
trap and Orbitrap are 4 m/z and 0.2 m/z, respectively. For each
peptide, the evaluation of differential amidination between acid-
ified and neutral conditions of HAwas calculated as integration
of modified peptide/integration of unmodified peptide.
Multiple reaction monitoring
MRM was performed on a Thermo TSQ Vantage with Easy-
nLC II. The digest was injected (Easy-nLC II) onto a C18
column and washed using a similar trapping set-up as de-
scribed above. Buffer A was 0.1% formic acid, and buffer B
was 100% acetonitrile, 0.1% formic acid. The peptides were
injected onto the trapping column at a flow rate of 2.50 μL/
min and separated on the analytical column at a flow rate of
230 nL/min. The gradient conditions were as follows: 0–
1 min: 0–7%B, 1–46 min: 7–33%B, 46–47 min: 33–80%B,
47–77 min: 80–90%B. Trapping and analytical columns were
equilibrated before every analysis. The elution time window
set for each peptide was 6 min. The spray voltage was set at
1.8 kVand the discharge current was 4.0 μA for all 3 quadru-
poles. Collision energies were calculated with the following
formula: CE = 0.03 × (precursor m/z) + 2.905 for 2+ charge
ions and CE = 0.038 × (precursor m/z) + 2.281 for 3+ charge
ions. The Q1 and Q3 peak width (FWHM) was set to 0.70 and
0.80, respectively. The cycle time was set to 800 ms. Each
peptide was integrated directly from its extracted ion chro-
matogram on Xcalibur.
Statistical analysis
Statistical analysis was performed in Excel. To compare the
amidination profile between acidified and neutral conditions,
we employed Student’s t test with the p value set to 0.05. For
the comparison of multiple treatments, one-way ANOVAwas
employed with the alpha factor set to 0.05, followed by
Tukey’s test. The sample size is indicated in the figure cap-
tions for each analysis. All data are expressed as means ±
standard deviations.
Results and discussion
Generation of a library of amidinated HA peptides
We chose PR8 HA (strain A/Puerto Rico/8/1934 H1N1) as
our nominal “wild-type” HA, as this subtype’s structure and
fusion has been widely studied [34]. To increase recombinant
PR8 yield by allowing secretion, the C-terminal trimerization
and membrane pass regions were replaced with a bacterial
foldon trimerization domain [35, 36]. This form has been val-
idated to form PR8 HA trimers that still undergo acid-
dependent fusion, as demonstrated by protease susceptibility
following acidic incubation [31]. We optimized cleavage of
full-length HA (HA0) to mature HA1/HA2 by brief TPCK
trypsinolysis (see Electronic Supplementary Material (ESM)
Fig. S1A). The two bands for HA2 represent glycoforms, as
confirmed by coalescence upon PNGase treatment (data not
shown). Furthermore, citrate acidification of mature HA1/
HA2 renders the protein more sensitive to further tryptic deg-
radation (Fig. 1a; lanes 3, 4) as opposed to the mature protein
in PBS (lanes 1, 2) or treated with an isotonic neutral citrate
buffer (Fig. 1a; lanes 5, 6). The tryptic sensitivity validates that
Table 1 Peptide sequences for reaction monitoring
Peptide Lysine Sequence (amidination site marked K) Charge state
1 K 62 R.LKGIAPLQLGK 2+
2 K 170 R.NLLWLTEKEGSYPK 2+
3 K 394 K.STQNAINGITNKVNTVIEK 2+
4 K 459 R.TLDFHDSNVKNLYEK 3+
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acidification promotes the conformational change to the post-
fusion state.
PR8 HA contains 37 lysine residues. To determine their
amidination profile, we prepared PR8 HA in both the pre-
and post-fusion states and treated each with 20 mM SMTA
for 30 min at pH 8.0 (Fig. 1b). SMTA selectively amidinates
lysine residues as this pH [24] (Fig. 1c). The reaction was
quenched by chloroform-methanol precipitation, and the pro-
tein reduced, alkylated, and digested by either Glu-C or tryp-
sin. Peptide sequences were determined by data-dependent
LC-MS/MS. Qualitatively similar results in peptide identifi-
cations were observed for both pre- and post-fusion HA;
hence, the following summarizes what was observed for the
post-fusion HA. With trypsin modification, we observed 75–
85% coverage of the protein (theoretical digest yields 86%
coverage by peptides with between 5 and 30 residues long),
with 0 lysines observed only with the modification, 9 lysines
observed solely without the modification, and 25 lysines ob-
served both with and without amidination (ESM Fig. S1B).
By contrast, Glu-C digestion yielded 60–65% coverage of the
protein (theoretical digest yields 68% coverage by peptides
between 5 and 30 residues long), with 0 lysines observed
solely with the modification, 14 lysines observed solely with-
out the modification, and 12 lysines observed both with and
without amidination (ESM Fig. S1B). These results are con-
sistent with previous findings that Glu-C yields peptides with
poorer chromatographic profile, greater variability in diges-
tion, and up to a threefold drop in unique peptide identifica-
tions [41]. Furthermore, the high density of Glu sites in the
HA2 region inherently limits the coverage that can be obtain-
ed with this protease. Hence, we moved forward with trypsin,
despite its inability to cleave amidinated lysine [19].
Interestingly, we found lysine amidination to be distributed
throughout the protein sequence, indicating that the PR8 HA
is accessible to SMTA across all domains (ESM Fig. S1C).
Labeling does not appear to be saturating, as although some
lysines were never observed to be modified, and other lysines
are identified from peptide-spectral matches in either the mod-
ified or unmodified state, there are no lysines that we only
observed to be amidinated.
Fig. 1 SMTA labeling of pre- and
post-fusion rHA. Silver stain of
SDS-PAGE separated recombi-
nant PR8 HA (rHA), demonstrat-
ing trypsin susceptibility follow-
ing acid-induced fusion. rHA
subjected to brief trypsin
precleavage (1:10 w/w TPCK-
treated trypsin in PBS for 5 min.,
37 °C, 600 rpm) was incubated in
either acidic or neutral citrate
buffer. Afterwards, all samples
were brought to pH 8.0, followed
by trypsin digestion at 37 °C for
30 min. as indicated. Dagger
symbol indicates small degrada-
tion products. Asterisk indicates
residual protein from the media
purification of HA, presumably
bovine serum albumen. Flow
chart for HA pre-cleavage, fusion,
neutralization, and SMTA label-
ing. Structures are of H3N2 from
PDB 1HA0 [37], 3HMG [38],
and 1HTM [39] and visualized in
NGL viewer [40]. Reaction
mechanism for SMTA modifica-
tion of the lysine amine. At neu-
tral or greater pH, deamination to
the imide is disfavored, driving
amidination as shown [24]
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Pseudo-PRM quantification of fusion-dependent HA
amidination
To identify peptides that could serve as markers of lysine
amidination, we evaluated the tryptic library (3 runs) for pep-
tides that met the following criteria [42]: (1) robustness of
identification, with ≥ 3 spectral counts in each run; (2) fully
tryptic; (3) no missed cleavage except for at the amidination
site; (4) containing lysines that were identified as both modi-
fied and unmodified, indicating that there is a dynamic range
of modification; (5) lacking methionine; (6) no K/R within 2
amino acids of the cleavage site (except for − 1 of course); and
(7) charge state of either 2 or 3. We identified 4 amidinated
peptides that were worth further consideration based on these
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Fig. 2 Differential amidination of Peptides 1–4 by SMTA. CID
fragmentation spectra collected on the LTQ for unmodified and
amidinated Peptide 1 during DDA analysis of acidified, SMTA-labeled
rHA digests prepared as in Fig. 1b. Identified b/y ions are indicated above
and below the peptide sequence. Scan ranges were determined by the
instrument. The transitions chosen for MRM, pseudo PRM and PRM
analysis are indicated by boxes. Extracted ion chromatograms for unmod-
ified and amidinated Peptide 1 analyzed during pseudo PRM in a LTQ
Velos ion trap, summed from transitions indicated in Fig. 2a. Pseudo-
PRM quantification of the amidination ratio for Peptides 1–4 in digests
of pre- or post-fusion rHA as indicated. The ratios of amidination are
determined from the AUC, as measured by pseudo-PRM, for each target
modified and unmodified peptide as described in Table 1. “Pre-fusion”
and “post-fusion” preparations are as in Fig. 1b. SMTA amidination is
performed with 20 mM SMTA, pH 7.0, 30 min at ambient temperature.
Error bars represent standard deviation. p values were determined by two-
tailed unpaired Student’s t test, n = 6 replicates prepared independently
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criteria. The three most intense transitions from the library
were used for each (Table 1, Fig. 2a, b and ESM Fig. S2A,
B). For normalization, we considered three internal reference
peptides [25]: the equivalent unlabeled peptide with missed
cleavage at the central lysine, the predicted cleavage product
for the unlabeled peptide with the lysine now available for
tryptic cleavage, and a peptide elsewhere in the protein gen-
erated through arginine cleavage (and hence presumably un-
affected by SMTA labeling). Surprisingly, despite the inher-
ently increased variance at missed cleavages, normalizing
amidinated peptides by the fully cleaved, non-amidinated pep-
tides yielded higher CV values (ESM Fig. S2C). Therefore,
we quantified the modification ratio at each lysine by taking
the ratio of the intensity of modified peptide over the intensity
of unmodified peptide. SMTA concentration was set to
20 mM, the minimum value that maximized this modification
ratio for any of the analyzed peptides (ESM Fig. S2D).
Because we are using an ion trap to characterize three transi-
tions in each peptide, as opposed to the Orbitrap traditionally
used for parallel reaction monitoring, we describe this ap-
proach as pseudo-PRM, analogous to pseudo-SRM, when
single transitions are monitored using an ion trap [25, 43].
Using this approach, we found that amidination at Peptide 1
(K62) on PR8 HA is significantly higher in the post-fusion
(acid-induced) conformational state (Fig. 2c). Peptide 1 is
located in the fusion (F′) subdomain of HA1, far from the
receptor binding site but in a region that undergoes substantial
variation with fusion and that stabilizes HA2 in the pre-fusion
state [2, 44]. More modest effects were observed at Peptide 2
(K170; increased amidination) and Peptide 4 (K459; de-
creased amidination), with no change observed at Peptide 3
(K394) (Fig. 2c). The change in amidination in part contrasts
with a previous HDX study on viral H3 hemagglutinin [2],
wherein Peptide 4 was found to become far more solvent
accessible upon fusion. The same study found a modest in-
crease in solvent accessibility post-fusion for the Peptide 1
region, with little change in the vicinity of the lysines in
Peptides 3 and 4. These differences could reflect differences
between serotypes, or the differences between D2O accessi-
bility and local lysine reactivity. Also, it is worthwhile to note
that these peptides are chosen as reporters of the conforma-
tional change that are best suited to reaction monitoring, rather
than being regions that themselves drive the fusion-associated
conformational change.
To validate that the conformational switch itself drove the
change in SMTA labeling, we considered two orthogonal
methods of blocking viral fusion. HA requires pre-cleavage
to free the fusion peptide and enable the conformational
change [45]. This pre-cleavage occurs physiologically by en-
dogenous host proteases, but can be accomplished in vitro
Fig. 3 The amidination assay is sensitive to conditions that interfere with
viral fusion. Amidination ratios for rHA that has not been tryptically pre-
cleaved, subject to acidification and labeling as in Fig. 1. Amidination
ratios at Peptide 1 in rHA prepared in either the pre- and post-fusion states
following pre-incubation with Arbidol (400 μM, 30 min), a fusion inhib-
itor, as indicated. “Pre-fusion” and “post-fusion” preparations are as in
Fig. 1. Error bars represent standard deviation. Significance was first
assessed by single factor ANOVA, followed by two-tailed Tukey’s post
hoc test. ANOVA F = 12, p < 10−4, **Tukey p < 0.002. n = 6 replicates
prepared independently. Amidination ratio at Peptide 4, as described in
Fig. 3b. ANOVA F = 8.3, p < 10−3, *Tukey p < 0.02. Arbidol structure
superimposed in the binding pocket on a crystal structure for unbound
PR8/HA, and with the amidination-prone lysines of Peptides 3 and 4
noted in green. Note that the PR8/HA structure would undoubtedly be
substantially distorted, as the binding pocket on this isotype is too narrow
to accommodate the inhibitor [47]
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through brief tryptic digestion [46]. In the absence of tryptic
pre-cleavage, no difference on Peptide 1 amidination of PR8
HA was observed between acidic and neutral incubation
(Fig. 3a). Because of the central role of fusion in viral entry
and infection, fusion inhibitors have been intensively investi-
gated as antiviral candidates. Arbidol (umifenavir) has been
reported to inhibit fusion of H1 serotype HA, including PR8,
at 400 μM [47]. We compared the amidination of target pep-
tides in the presence or absence of arbidol, as well as under
neutral or acid incubation conditions. Consistent with the
amidination fingerprint serving as a reporter of fusion compe-
tence, acidification in the presence of arbidol yielded an
amidination profile similar to that of HA that was never ex-
posed to low pH in Peptide 1 (Fig. 3b). Similar, though not
statistically significant (ANOVA p = 0.07), effects were
observed for Peptide 2 (ESM Fig. S3A). Furthermore, in sup-
port of this effect being mediated by a direct binding event,
Peptides 3 and 4, which are present near the arbidol binding
pocket (Fig. 3c), demonstrated decreased amidination across
conditions (Fig. 3d and ESM Fig. S3B), consistent with
arbidol’s presence in the pocket lowering the accessibility of
this residue. In summary, both biochemical and chemical in-
hibition of fusion yield an electrophilic footprint resembling
the pre-fusion state.
Sensitivity and robustness
To determine the sensitivity of the approach, we measured the
LOD for modified and amidinated Peptide 1 with respect to
rHA, finding 190 and 180 fmol respectively (Table 2,
Fig. 4a), with linear response up to 3 pmol. Similar LOD were
identified for the other profiled peptides (Table 2, ESM Fig.
S4). Although these LODs are high with respect to typical
MRM and PRM thresholds, it should be stressed that these
are with respect to the total HA protein concentration, rather
than the levels of peptide. The amidination ratio is robust to
concentration over this range (Fig. 4b). We also considered that
the injection time could bias the observed ratio [25]; we main-
tained an AGC of 104 while varying injection time (Fig. 4c).
Longer injection times allow variance in cycle time when the
AGC target is reached, while weaker signals with lower injec-
tion times can lead to measurement artifacts due to the Xcalibur
Fig. 4 Sensitivity of pseudo-PRM measurement of Peptide 1. Linear
relationships between AUCs for modified and amidinated Peptide 1 and
the amount of PR8 injected. Minimal dependence of the modification
ratio of Peptide 1 on the amount of PR8 HA loaded between 13 and
200 ng. Minimal dependence of the modification ratio of Peptide 1 on
the injection time into the ion trap. Error bars represent standard devia-
tion. MRM quantification of Peptide 1 in rHA digests on a triple-
quadrupole mass spectrometer. Significance was first assessed by single
factor ANOVA, followed by two-tailed Tukey’s post hoc test. ANOVA
F = 6.0, p < 0.005. n = 6 replicates prepared independently
Table 2 LODs (from
standard deviation of the
response) for HA
peptides
Peptide Amidination state fmol HA
1 Unmodified 188
Modified 178
2 Unmodified 228
Modified 235
3 Unmodified 290
Modified 252
4 Unmodified 78
Modified 109
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noise filter [48]. Interestingly, the ratio does not change with
injection time, indicating that the AGC target is not getting
achieved; the cycle time is consistent across each peak.
However, at lower injection times, the variance does increase.
To compare to a more traditional MRM approach, we further
evaluated amidination of Peptide 1 on a TSQ Quantiva triple
quadrupole mass spectrometer. Similar results to those obtained
using pseudo-PRM (Fig. 3b) were observed, but with greater
variation (Fig. 4d).
Evaluation of a mutant form of rHA
A chimeric rHA (cHA) is a mutant form of rHA, which is
composed of the head from one HA subtype and the stalk
domain from the other [28]. These play an important role in
emerging strategies for universal influenza vaccine develop-
ment [49]. The lack of a fusion assay has limited our
understanding of the function of the cHA. To this end, we
evaluated amidination of one such chimera, cH6/1
(Fig. 5a, b; head fromA/mallard/Sweden/81/02 and stalk from
A/Puerto Rico/08/34), which contains Peptide 4 in its PR8
HA stalk domain and whose virus is challenging to generate
de novo, implying impaired HA function. Unlike in native
PR8 HA, amidination of Peptide 4 in cH6/1 does not decrease
following acidification (Fig. 5b), indicating that its conforma-
tion is less influenced by acidification, and perhaps less fu-
sion-competent, than that of native PR8 HA.
PRM for detection in complex mixtures
Ultimately, the benefit of PRM profiling of HA fusion, as
compared to HDX, would be to identify the fusion-
associated conformational switch in complex biological mi-
lieu. To evaluate our methods’ performance in complex
Fig. 6 Pseudo-PRM (ion trap) and PRM (orbitrap) in lysate. Differential
amidination at peptide 1 on rHA in the presence or absence of tryptically
digested HEK293T lysate. Error bars represent standard deviation.
Significance determined from 2-tailed unpaired Student’s t test (n = 3
independently prepared samples). Differential amidination of 1 μg HA
spiked into 5 μg HEK293T lysate prepared by the freeze-thaw method,
then SMTA-labeled, digested and analyzed by PRM in the Orbitrap. Error
bars represent standard deviation. Significance determined from two-
tailed unpaired Student’s t test (n = 6 independently prepared samples)
Fig. 5 Schematic illustrating the design of chimeric c6/1 HA, and com-
parison to the PR8 HA sequence. Locations ofPeptides 1–4 are indicated.
Peptides 1 and 2 are located in the head region of PR8 HA and hence are
absent in the c6/1 HA chimera. Differential amidination of Peptide 4
between pre- and post-fusion states of c6/1 HA
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mixtures, we spiked rHA digest into a HEK293T lysate, and
compared the measurement of amidination to rHA digest in
buffer, as well as between the use of the LTQ ion trap and the
Orbitrap (Fig. 6a). Both traps perform well, but the high-
resolution Orbitrap does decrease variance as opposed to the
ion trap. As with the ion trap, no dependence of the modifica-
tion ratio on injection time was observed (ESM Fig. S5A).
Lysate added to labeled PR8HAprior to tryptic digestion does
not affect the Peptide 1modification ratio. We also considered
adding PR8 HA to the lysate prior to labeling. Interestingly,
lysate prepared with high detergent RIPA buffer does affect
the observed SMTA labeling, but lysate prepared by freeze-
thaw of cells in PBS does not affect the PR8 HAmodification
ratios measured by PRM (Fig. 6b).
Conclusions
This study represents the first reported effort to combine elec-
trophilic profiling and reaction monitoring. We profiled two
different conformations of rHA: the pre-fusion state and the
acid-induced post-fusion state. These two states demonstrate
different susceptibility to electrophilic modification at lysine
by the labeling reagent SMTA. The reliance of differential
amidination on fusion is validated by its dependence on HA
pre-cleavage and the loss of differential amidination upon pre-
incubation with the fusion inhibitor Arbidol. Furthermore, the
homogeneity of the labeling product allowed straightforward
mass spectrometric quantification through MRM on a triple
quadrupole instrument, pseudo-PRM in a linear ion trap, and
PRM in an Orbitrap mass analyzer. Surprisingly, we find that
normalization to non-amidinated peptides harboring a missed
cleavage as the internal reference peptides provides robust
quantification. The ability to discriminate between pre- and
post-fusion states, and the robustness of the assay in the pres-
ence of complex matrix interferences, suggests that this ap-
proach will allow quantification of intracellular hemagglutinin
fusion competence.
One potential application of this approach is to characterize
how sequence influences HA fusion competence. Another
long-term goal of this methodology is to identify HA fusion
yield inside the cell. Under this scheme, we find limits of
detection in the 100 to 300 fmol range with respect to HA.
At 1000 molecules of HA per virion [50], profiling cells at a
multiplicity of infection of 10 would yield about 2 fmol HA in
a well of a 96-well plate, above the 0.1 to 1 fmol range often
achieved for peptide detection using isotope dilution MRM
[43, 51]. This method could similarly benefit from isotopically
labeled standards. One inherent limitation is the constriction
of peptide choice as compared to total protein quantification,
wherein the peptides with the best signal, robustness, and
freedom from interferences can be chosen. It is possible that
in this respect, the product heterogeneity associated with more
promiscuous labeling methods such as FPOP might be supe-
rior, as the diversity of products increases the number of po-
tential precursor ions that report on individual conformational
changes. On the other hand, greater diversity of products
might lower the sensitivity to any individual product.
Further investigations will compare amidination to other pro-
tein labeling strategies as a method to identify HA conforma-
tional changes by reaction monitoring of covalent labeling
products.
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